文献速递围术期管理与 ERAS

C反应蛋白-白蛋白-淋巴细胞指数可预测冠脉搭桥术后长期死亡率

The C-reactive protein-albumin-lymphocyte index as a novel predictor of long-term mortality after coronary bypass grafting: An international multicenter retrospective study.
PubMed 文献 · Surgery · 2026-05-22

这项国际多中心回顾性队列研究纳入6883例接受单纯冠状动脉旁路移植术的成人,评估术前C反应蛋白-白蛋白-淋巴细胞指数(CALLY)与术后30天及长期全因死亡率的关系。中位随访79.7个月,高CALLY组(>27.28)相比低CALLY组(<12.54)30天死亡率(aHR 0.41,95%CI 0.21-0.76)和长期死亡率(aHR 0.76,95%CI 0.59-0.96)均显著降低,提示CALLY可能改善围术期风险分层。

要点

  • 高CALLY(>27.28)与冠脉搭桥术后30天死亡率降低独立相关(aHR 0.41)。
  • 高CALLY与长期全因死亡率降低独立相关(aHR 0.76)。
  • CALLY与长期死亡率呈非线性负相关,10年RMST在高CALLY组延长0.76年。

核心结论

  • CALLY可预测冠状动脉旁路移植术后30天和长期全因死亡率,可能改善围术期风险分层。

研究设计与样本

  • 国际多中心回顾性队列研究,纳入6883例接受单纯冠状动脉旁路移植术的成人。
  • 主要终点为长期全因死亡率(从手术至可获得长期随访期间,每年评估生存状态),次要终点为30天死亡率。
  • 术前CALLY按三分位分组:低<12.54,中12.54-27.28,高>27.28,并作为连续变量分析。
  • 采用按中心分层的Cox比例风险模型并调整相关协变量,使用限制性立方样条检验非线性关系,并估计5年和10年的限制性平均生存时间(RMST)。

主要发现

  • 中位随访79.7个月,共发生623例长期死亡,其中96例为30天内死亡。
  • 30天死亡率随CALLY三分位升高而下降:低组2.1%,中组1.2%,高组0.6%。
  • 多变量调整后,高CALLY组相比低CALLY组30天死亡率更低(aHR 0.41,95%CI 0.21-0.76),中CALLY组与30天死亡率无显著关联(aHR 0.71,95%CI 0.44-1.16)。
  • 高CALLY组与长期死亡率降低独立相关(aHR 0.76,95%CI 0.59-0.96),中CALLY组调整后无统计学显著性(aHR 0.85,95%CI 0.69-1.05)。
  • 10年时,中和高CALLY组调整后RMST较低CALLY组更长,10年RMST horizon内平均生存获益分别为0.64年和0.76年。

临床怎么用

  • 术前可计算CALLY(整合C反应蛋白、白蛋白和淋巴细胞)辅助识别冠脉搭桥术后高死亡风险患者。
  • 高CALLY(>27.28)提示30天和长期死亡风险较低,低CALLY(<12.54)提示风险较高,可据此加强围术期管理。
  • CALLY可作为现有风险分层工具的补充指标,但需结合其他临床因素综合评估。

局限性

  • 回顾性队列设计可能存在残余混杂。
  • 研究仅纳入接受单纯冠状动脉旁路移植术的成人,结论外推需谨慎。
  • CALLY与长期死亡率的关联在中组未达统计学显著性,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite advances in perioperative care, risk stratification after cardiac surgery remains imperfect. The C-reactive protein-albumin-lymphocyte index integrates inflammation, nutrition, and immune function. We evaluated its association with short- and long-term mortality after coronary artery bypass grafting. METHODS: We conducted a multicenter retrospective cohort study of 6,883 adults undergoing isolated coronary artery bypass grafting. The primary endpoint was long-term all-cause mortality, defined as mortality from surgery through the available long-term follow-up period, with mortality status assessed annually; the secondary endpoint was 30-day mortality. The preoperative C-reactive protein-albumin-lymphocyte index was analyzed as tertiles, low <12.54, middle 12.54-27.28, and high >27.28, and as a continuous variable. Associations were assessed using Cox proportional hazards models stratified by center and adjusted for relevant covariates. Restricted cubic splines examined nonlinear relationships, and the restricted mean survival time (RMST) was estimated at 5 and 10 years. RESULTS: During a median follow-up of 79.7 months, 623 long-term deaths occurred, including 96 deaths within 30 days. Thirty-day mortality decreased across C-reactive protein-albumin-lymphocyte tertiles: 2.1% in the low group, 1.2% in the middle group, and 0.6% in the high group. After multivariable adjustment, the high C-reactive protein-albumin-lymphocyte group remained associated with lower 30-day mortality compared with the low group (adjusted hazard ratio, 0.41; 95% confidence interval, 0.21-0.76), whereas the middle C-reactive protein-albumin-lymphocyte group was not significantly associated with 30-day mortality (adjusted hazard ratio, 0.71; 95% confidence interval, 0.44-1.16). For long-term mortality, the high C-reactive protein-albumin-lymphocyte group remained independently associated with lower risk (adjusted hazard ratio, 0.76; 95% confidence interval, 0.59-0.96), whereas the association for the middle C-reactive protein-albumin-lymphocyte group did not reach statistical significance after adjustment (adjusted hazard ratio, 0.85; 95% confidence interval, 0.69-1.05). At 10 years, adjusted (RMST) was longer in the middle and high C-reactive protein-albumin-lymphocyte groups compared with the low C-reactive protein-albumin-lymphocyte group, corresponding to average survival gains of 0.64 years and 0.76 years, respectively, over the 10-year RMST horizon. Spline analysis demonstrated a nonlinear inverse association between C-reactive protein-albumin-lymphocyte and long-term mortality. CONCLUSION: The C-reactive protein-albumin-lymphocyte index predicts 30-day and long-term all-cause mortality after coronary artery bypass grafting and may improve perioperative risk stratification.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Abu Khadija H, Alnees M, Ibraheem K, et al. The C-reactive protein-albumin-lymphocyte index as a novel predictor of long-term mortality after coronary bypass grafting: An international multicenter retrospective study. Surgery. 2026. PMID: 42341719. doi:10.1016/j.surg.2026.110334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。